Artesunate + Mefloquine is a combination antimalarial medicine used to treat acute uncomplicated malaria caused by the parasite Plasmodium falciparum.
This combination is commonly used for:
• Uncomplicated Plasmodium falciparum malaria: Treats acute uncomplicated malaria caused by Plasmodium falciparum.
• Completion of treatment after severe malaria: Used following initial injectable artesunate therapy to complete treatment of severe malaria.
Nausea
Vomiting
Abdominal pain
Fatigue
Diarrhoea
Artesunate + Mefloquine works through two separate mechanisms that target and destroy the malaria parasite in the blood.
Artesunate is derived from artemisinin. It is activated within the malaria parasite to produce free radicals that damage parasite proteins and other essential cellular components, leading to parasite death.
Mefloquine is a quinoline compound. It is thought to interfere with haem detoxification within the malaria parasite, leading to the accumulation of toxic haem products that kill the parasite.
Together, Artesunate and Mefloquine destroy the malaria parasite during the blood stage of infection and help reduce the risk of treatment failure and the development of drug resistance.

MSc (Applied Genetics)

Bachelor of Dental Surgery
Artesunate + Mefloquine is available via the oral route (tablet), intravenous or intramuscular route (injection).
This combination medicine is meant for both adults and children. However, for children, dose adjustments are necessary based on body weight.
Artesunate + Mefloquine is contraindicated in patients with known hypersensitivity to either Artesunate or Mefloquine.
It is also contraindicated in patients with a history of psychiatric disorders or seizures associated with Mefloquine use.
Lastly, it is not recommended for patients with severe hepatic impairment.
Artesunate + Mefloquine may interact with strong CYP3A4 inducers (such as rifampin and phenytoin), and strong CYP3A4 inhibitors (like ketoconazole and ritonavir), and medications that prolong the QTc interval (like quinolones, macrolides, and tricyclic antidepressants).
If you miss a dose of Artesunate + Mefloquine, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and continue with your regular schedule. Do not take a double dose to make up for the missed one.
Most side effects are temporary and generally harmless and resolve when discontinuing this medicine. However, if you experience any severe side effects or worsening of any of the symptoms, please consult your doctor.
Drinking plenty of fluids can help manage some gastrointestinal side effects like diarrhoea and abdominal pain.
Rest and relaxation techniques can help manage the side effects of the nervous system, such as headaches and dizziness.
Artesunate + Mefloquine may cause dizziness or fatigue in some individuals. If affected, avoid driving or operating heavy machinery.
Artesunate + Mefloquine should only be used during pregnancy if clearly needed and the benefits outweigh potential risks. It is advised that breastfeeding mothers should avoid this medication. Always consult your doctor before using this medicine during pregnancy or lactation.
Individuals with cardiac conduction abnormalities or arrhythmias should exercise caution when taking Artesunate + Mefloquine.
This medicine should also be used cautiously by individuals with electrolyte disturbances (like hypokalaemia, and hypomagnesaemia) and renal impairment.
Drink plenty of fluids to stay hydrated, which can help with the management of diarrhoea.
Avoid alcohol consumption, as it may enhance the sedative effect of this medicine.
Get adequate rest to help manage fatigue or sleep disturbances.
Frequently asked questions
No, Artesunate + Mefloquine is not an antibiotic. It is a specific combination medicine used for managing malaria caused by the Plasmodium falciparum parasite.
Yes, some people may experience common side effects such as nausea and vomiting after taking Artesunate + Mefloquine.
Yes, one of the potential side effects of Artesunate + Mefloquine is palpitations or slow heart rate (bradycardia).
Yes, Artesunate + Mefloquine can interact with other medicines, particularly those that are metabolised by the enzyme CYP3A4.
Yes, Artesunate + Mefloquine can be given to children for managing acute uncomplicated P. falciparum malaria, but the dosage would need to be adjusted according to their body weight.
Artesunate + Mefloquine is taken only as per the doctor's recommendation. Long-term daily use is not typically recommended unless advised by your doctor.
The best time to take Artesunate + Mefloquine is as per your doctor's prescription.
Artesunate + Mefloquine in other salts
Company
About UsHealth ArticleHealth StoriesHealth LibraryDiseases & Health ConditionsAyurvedaUnderstanding Generic MedicinesAll MedicinesAll BrandsNeed HelpFAQSecuritySavings CalculatorAdvertise with UsSubscribe
Registered Office Address
Grievance Officer
Download Truemeds
Contact Us
Our customer representative team is available 7 days a week from 9 am - 9 pm.
v4.28.8
2026 - Truemeds | All rights reserved. Our content is for informational purposes only. See additional information.
Our Payment Partners

